These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 12055988)
21. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy. Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596 [TBL] [Abstract][Full Text] [Related]
22. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Portes ES; Oliveira JH; MacCagnan P; Abucham J Clin Endocrinol (Oxf); 2000 Aug; 53(2):183-9. PubMed ID: 10931099 [TBL] [Abstract][Full Text] [Related]
23. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. Giusti M; Foppiani L; Ponzani P; Cuttica CM; Falivene MR; Valenti S J Endocrinol Invest; 1997 May; 20(5):257-63. PubMed ID: 9258804 [TBL] [Abstract][Full Text] [Related]
24. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Jørgensen JO; Møller J; Laursen T; Orskov H; Christiansen JS; Weeke J Clin Endocrinol (Oxf); 1994 Nov; 41(5):609-14. PubMed ID: 7828350 [TBL] [Abstract][Full Text] [Related]
25. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa. Duclos M; Corcuff JB; Roger P; Tabarin A Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977 [TBL] [Abstract][Full Text] [Related]
26. [Hormonal changes and pituitary histological and immunocytochemical studies of patients with multiple organ failure]. Sumita S Masui; 1994 Oct; 43(10):1541-51. PubMed ID: 7815707 [TBL] [Abstract][Full Text] [Related]
27. [Leptin and it's potential role in the pathomechanism of some hormonal and metabolic disorders of patients with anorexia nervosa]. Smiarowska M Ann Acad Med Stetin; 2002; 48():351-65. PubMed ID: 14601488 [TBL] [Abstract][Full Text] [Related]
28. Obesity and endocrine disease. Kokkoris P; Pi-Sunyer FX Endocrinol Metab Clin North Am; 2003 Dec; 32(4):895-914. PubMed ID: 14711067 [TBL] [Abstract][Full Text] [Related]
29. [Serum free thyroid hormones and response of TSH to TRH in nonthyroidal illnesses]. Kokei S; Inoue T; Iino S Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1231-43. PubMed ID: 3100346 [TBL] [Abstract][Full Text] [Related]
30. Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. Croxson MS; Ibbertson HK J Clin Endocrinol Metab; 1977 Jan; 44(1):167-74. PubMed ID: 401822 [TBL] [Abstract][Full Text] [Related]
31. The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness. Gianotti L; Broglio F; Ramunni J; Lanfranco F; Gauna C; Benso A; Zanello M; Arvat E; Ghigo E Eat Weight Disord; 1998 Jun; 3(2):64-70. PubMed ID: 10728152 [TBL] [Abstract][Full Text] [Related]
32. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192 [TBL] [Abstract][Full Text] [Related]
33. The effect of a low-calorie diet alone and in combination with triiodothyronine therapy on weight loss and hypophyseal thyroid function in obesity. Koppeschaar HP; Meinders AE; Schwarz F Int J Obes; 1983; 7(2):123-31. PubMed ID: 6408016 [TBL] [Abstract][Full Text] [Related]
34. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314 [TBL] [Abstract][Full Text] [Related]
35. Peripheral resistance to thyroid hormone in an infant. Kaplowitz PB; D'Ercole AJ; Utiger RD J Clin Endocrinol Metab; 1981 Nov; 53(5):958-63. PubMed ID: 6793616 [TBL] [Abstract][Full Text] [Related]
36. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Lanfranco F; Gianotti L; Pivetti S; Navone F; Rossetto R; Tassone F; Gai V; Ghigo E; Maccario M Clin Endocrinol (Oxf); 2004 Jan; 60(1):41-8. PubMed ID: 14678286 [TBL] [Abstract][Full Text] [Related]
37. Effects of nonthyroidal illness on thyroid function. Tibaldi JM; Surks MI Med Clin North Am; 1985 Sep; 69(5):899-911. PubMed ID: 3932793 [TBL] [Abstract][Full Text] [Related]
38. [Anorexia nervosa: endocrine function during the phases of body weight loss and recovery]. Méndez JP; García E; Salinas JL; Pérez-Palacios G; Ulloa-Aguirre A Rev Invest Clin; 1989; 41(4):337-44. PubMed ID: 2517152 [TBL] [Abstract][Full Text] [Related]
39. The pituitary-thyroid axis in acromegaly. Eskildsen PC; Kruse A; Kirkegaard C Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541 [TBL] [Abstract][Full Text] [Related]
40. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella. Cannavò S; Curtò L; Venturino M; Squadrito S; Almoto B; Narbone MC; Rao R; Trimarchi F J Endocrinol Invest; 2002 Mar; 25(3):236-9. PubMed ID: 11936465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]